March 2010 Approvals
This article was originally published in Pharmaceutical Approvals Monthly
You may also be interested in...
The chair of FDA's Arthritis Drugs Advisory Committee, Kathleen O'Neil, University of Oklahoma, is co-investigator in a trial of another drug for systemic lupus erythematosus.
Redeeming a priority review voucher obtained by developing a drug for a tropical disease will cost companies $6.1 million in fiscal 2011